Emcure receives EIR report for its formulations facility at Sanand, Gujarat
(08 Aug 2026)

Back
Emcure Pharmaceuticals announced that the Company has received the Establishment Inspection Report (EIR) from the USFDA for its formulations facility located at G.I.D.C., Taluka - Sanand, Ahmedabad. The USFDA has classified the inspection status of the said facility as Voluntary Action Indicated (VAI) and accordingly, the inspection stands closed.

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew